Upstream solutions for price-gouging on critical generic medicines

Mayo Clinic Center for Tuberculosis. Update on the Cycloserine Capsule Price Increase. 2015. https://web.archive.org/web/20151016132525/http://centerfortuberculosis.mayo.edu/the-latest-on-tb/archives/09-2015 . Accessed 10 Nov 2015.

Pollack A. Drug Goes from $13.50 a Tablet to $750, Overnight. 2015. The New York Times. http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html?_r=0 . Accessed 10 Nov 2015.

McCarthy M. US Senate committee launches investigation into drug pricing. BMJ. 2015;351:h5989.

Conti RM, Rosenthal MB. Pharmaceutical Policy Reform — Balancing Affordability with Incentives for Innovation. N Engl J Med. 2016;374:703–6.

Eli Lilly and Company. White Paper: Seeking Solutions to a Global Health Crisis. 2014. www.lillyglobalhealth.com/en/media/pdfs/mdr-tb-technology-transfer.pdf . Accessed 20 Sept 2015.

Pollack A. Big Price Increase for TB Drug Is Rescinded. The New York Times. http://www.nytimes.com/2015/09/22/business/big-price-increase-for-tb-drug-is-rescinded.html?_r=0 . Accessed 10 Nov 2015.

Ramsey L. Big Pharma CEOs on Martin Shkreli: ‘He is not us’. Business Insider. http://www.businessinsider.com/big-pharma-ceos-distance-themselves-from-turings-martin-shkreli-2015-12 . Accessed 10 Feb 2016.

Gupta R, Kim JY, Espinal MA, et al. Responding to Market Failures in Tuberculosis Control. Science. 2001;293:1049–51.

Discontinuance or interruption in the production of life-saving drugs. 21 U.S. Code § 356c. 2012. https://www.gpo.gov/fdsys/granule/USCODE-2012-title21/USCODE-2012-title21-chap9-subchapV-partA-sec356c . Accessed 10 Feb 2016.

Transfer of Slots. 14 CFR 93.221 (a) (6). 2011. https://www.gpo.gov/fdsys/granule/CFR-2011-title14-vol2/CFR-2011-title14-vol2-sec93-221/content-detail.html . Accessed 10 Feb 2016.